Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

Drug pricing should depend on shared values

Paying for cancer immunotherapy will require new ways of cooperation between drug companies, insurers and policymakers, says Scott Ramsey.
  1. Scott Ramsey

    1. Scott Ramsey is a physician, health economist and director of the Hutchinson Institute for Cancer Outcomes Research in Seattle, Washington.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Immunotherapy has moved to the forefront of cancer research and is being adopted rapidly into oncology practice. It is good news for people with cancer, but the success comes at a cost.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 552, S78 (2017)

doi: https://doi.org/10.1038/d41586-017-08314-1

This article is part of Nature Outlook: Cancer immunotherapy, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Rahib, L. et al. Cancer Res. 74, 2913–2921 (2014).

    Article  PubMed  CAS  Google Scholar 

  2. Institute for Clinical and Economic Review. Treatment Options for Advanced Non-Small Cell Lung Cancer: Effectiveness, Value and Value-Based Price Benchmarks; available at: http://go.nature.com/2yyalic

  3. Carlson, J. J., Sullivan, S. D., Garrison, L. P., Neumann, P. J. & Veenstra, D. L. Health Policy 96, 179–190 (2010).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

S.R. is a consultant at Bayer, Genentech, BMS and Kite Pharma, and has received research grants from the Personalized Medicine Coalition.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links